fluoxetine has been researched along with Chronic Kidney Diseases in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Excerpt | Relevance | Reference |
---|---|---|
"In total, 3252 Chronic Renal Insufficiency Cohort participants with at least one study electrocardiogram between 2003 and 2011 were included." | 1.46 | Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. ( Delafontaine, P; Deo, R; Doerfler, RM; Fink, JC; Fischer, MJ; Jaar, BG; Kramlik, S; Makos, GK; Navaneethan, S; Ojo, A; Slaven, A; Snitker, S; Soliman, EZ; St Peter, WL; Weir, MR; Zhan, M, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Snitker, S | 1 |
Doerfler, RM | 1 |
Soliman, EZ | 1 |
Deo, R | 1 |
St Peter, WL | 1 |
Kramlik, S | 1 |
Fischer, MJ | 1 |
Navaneethan, S | 1 |
Delafontaine, P | 1 |
Jaar, BG | 1 |
Ojo, A | 1 |
Makos, GK | 1 |
Slaven, A | 1 |
Weir, MR | 1 |
Zhan, M | 1 |
Fink, JC | 1 |
1 other study available for fluoxetine and Chronic Kidney Diseases
Article | Year |
---|---|
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Citalopram; Diab | 2017 |